Applied DNA Sciences, Inc. (BNBX) — Financial Flexibility Index
Applied DNA Sciences, Inc. (BNBX) has a Financial Flexibility Index of -2.48x as of December 2025. Free cash flow of $-5.55 Million (operating CF $-5.55 Million minus capex $0.00) represents -2% of total liabilities ($2.24 Million). Also explore Applied DNA Sciences, Inc. (BNBX) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Applied DNA Sciences, Inc. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Applied DNA Sciences, Inc. across 5 annual periods. See BNBX net asset quality score to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Applied DNA Sciences, Inc. (2021–2025)
Year-by-year free cash flow to debt coverage for Applied DNA Sciences, Inc.. For the full company profile including market capitalisation, see how much is Applied DNA Sciences, Inc. worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.89x | $-12.21 Million | $-12.52 Million | $2.50 Million | ▼ -40.5% |
| 2024 | -3.48x | $-13.30 Million | $-13.71 Million | $3.82 Million | ▼ -397.9% |
| 2023 | -0.70x | $-6.14 Million | $-6.22 Million | $8.78 Million | ▲ +22.9% |
| 2022 | -0.91x | $-8.49 Million | $-8.98 Million | $9.36 Million | ▲ +72.4% |
| 2021 | -3.28x | $-10.84 Million | $-13.39 Million | $3.30 Million | — |